Zobrazeno 1 - 10
of 2 782
pro vyhledávání: '"Schraermeyer U"'
Autor:
Zhao S; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.; Present address: Molecular mechanisms driving age-related macular degeneration, Experimental Vitreoretinal Surgery Group Centre for Ophthalmology, Institute for Ophthalmic Research, University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany., Tschulakow AV; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.; OcuTox GmbH Preclinical Drug Assessment Hechingen Germany.; Present address: Molecular mechanisms driving age-related macular degeneration, Experimental Vitreoretinal Surgery Group Centre for Ophthalmology, Institute for Ophthalmic Research, University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany., Karthikeyan SS; Department of Gene Therapy University Clinic Ulm Germany., Wang K; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.; Present address: Molecular mechanisms driving age-related macular degeneration, Experimental Vitreoretinal Surgery Group Centre for Ophthalmology, Institute for Ophthalmic Research, University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany., Kochanek S; Department of Gene Therapy University Clinic Ulm Germany., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.; OcuTox GmbH Preclinical Drug Assessment Hechingen Germany., Julien-Schraermeyer S; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.; OcuTox GmbH Preclinical Drug Assessment Hechingen Germany.; Present address: Molecular mechanisms driving age-related macular degeneration, Experimental Vitreoretinal Surgery Group Centre for Ophthalmology, Institute for Ophthalmic Research, University Medical Center, Eberhard Karls University of Tuebingen Tuebingen Germany.
Publikováno v:
FASEB bioAdvances [FASEB Bioadv] 2024 Jul 19; Vol. 6 (9), pp. 311-326. Date of Electronic Publication: 2024 Jul 19 (Print Publication: 2024).
Autor:
Wang K; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany., Lyu Y; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China., Tschulakow AV; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany.; Ocutox, Preclinical Drug Assessment, Hechingen 72379, Germany., Brash DE; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040.; Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8028., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany.; Ocutox, Preclinical Drug Assessment, Hechingen 72379, Germany.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 31; Vol. 120 (44), pp. e2315582120. Date of Electronic Publication: 2023 Oct 23.
Autor:
Lyu Y; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany., Tschulakow AV; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany.; OcuTox GmbH, Preclinical Drug Assessment, Hechingen 72379, Germany., Wang K; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany., Brash DE; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040.; Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT 06520-8028., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tuebingen, Tuebingen 72076, Germany.; OcuTox GmbH, Preclinical Drug Assessment, Hechingen 72379, Germany.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 May 16; Vol. 120 (20), pp. e2216935120. Date of Electronic Publication: 2023 May 08.
Publikováno v:
In Micron 2006 37(3):262-276
Autor:
Xi L; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Tikhonovich M; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Biesemeier A; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Julien-Schraermeyer S; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany., Tschulakow AV; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany.
Publikováno v:
Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Aug 05; Vol. 2022, pp. 4199394. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Autor:
Arnhold, S. *, Semkova, I., Andressen, C., Lenartz, D., Meissner, G., Sturm, V., Kochanek, S., Addicks, K., Schraermeyer, U.
Publikováno v:
In Experimental Neurology 2004 187(2):410-417
Autor:
Oh M; Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul, 02841, Republic of Korea., Yeom J; Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul, 02841, Republic of Korea., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tübingen, 72076, Tübingen, Germany., Julien-Schraermeyer S; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, University of Tübingen, 72076, Tübingen, Germany., Lim YH; Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul, 02841, Republic of Korea. yhlim@korea.ac.kr.; School of Biosystems and Biomedical Sciences, Korea University, Seoul, 02841, Republic of Korea. yhlim@korea.ac.kr.; Department of Laboratory Medicine, Korea University Guro Hospital, Seoul, 08308, Republic of Korea. yhlim@korea.ac.kr.
Publikováno v:
Scientific reports [Sci Rep] 2022 May 03; Vol. 12 (1), pp. 7161. Date of Electronic Publication: 2022 May 03.
Autor:
Fang Y; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Tschulakow A; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; Preclinical Drug Assessment, STZ Ocutox, Hechingen, Germany., Taubitz T; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Illing B; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Biesemeier A; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Julien-Schraermeyer S; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; Preclinical Drug Assessment, STZ Ocutox, Hechingen, Germany., Radu RA; UCLA Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Jiang Z; UCLA Stein Eye Institute, Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Institute of Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.; Preclinical Drug Assessment, STZ Ocutox, Hechingen, Germany.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2020 Mar; Vol. 34 (3), pp. 3693-3714. Date of Electronic Publication: 2020 Jan 27.
Autor:
Fang Y; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Taubitz T; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Tschulakow AV; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany., Heiduschka P; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Szewczyk G; Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland., Burnet M; Synovo GmbH, Tuebingen, Germany., Peters T; Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany., Biesemeier A; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany., Sarna T; Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland., Schraermeyer U; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany., Julien-Schraermeyer S; Division of Experimental Vitreoretinal Surgery, Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany; STZ Ocutox, Preclinical Drug Assessment, Hechingen, Germany. Electronic address: Sylvie.Julien@med.uni-tuebingen.de.
Publikováno v:
Free radical biology & medicine [Free Radic Biol Med] 2022 Mar; Vol. 182, pp. 132-149. Date of Electronic Publication: 2022 Feb 25.
Autor:
Nagano, Norimichi1 (AUTHOR), Hirano, Yoshio2 (AUTHOR), Kimura, Masayo2 (AUTHOR), Morita, Hiroshi2 (AUTHOR), Yasukawa, Tsutomu2 (AUTHOR) yasukawa@med.nagoya-cu.ac.jp
Publikováno v:
Stem Cell Research & Therapy. 12/23/2024, Vol. 15 Issue 1, p1-13. 13p.